Krainer Adrian R.

Track

Insider profile

Krainer Adrian R.'s trades of Stoke Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
171.45
Quantity 54,010
Value US$2,954,115
Transaction date
Planned sale
Price
29.72
Quantity 40,472 -11.1%
Value US$1,202,719
Transaction date
Proposed sale
Price
29.34
Quantity 40,472
Value US$1,187,448
Transaction date
Proposed sale
Price
26.07
Quantity 40,472
Value US$1,055,105
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-12 2026-03-10
PlS Planned sale
46,802 -41.0%
295.22
US$700,963 		46,802 -41.0% 295.22 US$700,963
2026-03-04 2026-03-02
PlS Planned sale
15,533 +3.2%
351.71
US$3,729,479 		15,533 +3.2% 351.71 US$3,729,479
2026-03-02 2026-03-02
PrS Proposed sale
54,010
171.45
US$2,954,115 		54,010 171.45 US$2,954,115
2025-11-26 2025-11-24
PlS Planned sale
40,472 -11.1%
29.72
US$1,202,719 		40,472 -11.1% 29.72 US$1,202,719
2025-11-24 2025-11-24
PrS Proposed sale
40,472
29.34
US$1,187,448 		40,472 29.34 US$1,187,448
2025-11-18 2025-11-14
PlS Planned sale
20,682 -5.4%
27.34
US$565,365 		20,682 -5.4% 27.34 US$565,365
2025-11-18 2025-11-14
PlS Planned sale
19,790 -4.9%
26.61
US$526,693 		19,790 -4.9% 26.61 US$526,693
2025-11-14 2025-11-14
PrS Proposed sale
40,472
26.07
US$1,055,105 		40,472 26.07 US$1,055,105